MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
L Zhu, X Liu, W Zhang, H Hu, Q Wang, K Xu - BMC cancer, 2022 - Springer
Background The bifunctional methylenetetrahydrofolate dehydrogenase (NADP+
dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2) has been reported to …
dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2) has been reported to …
Upregulation of MTHFD2 is associated with PD-L1 activation in bladder cancer via the PI3K/AKT pathway
X Deng, X Liu, B Hu, J Liu, B Fu… - … Journal of Molecular …, 2022 - spandidos-publications.com
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) has been implicated in the etiology
of various human malignant tumors; however, its exact role in bladder cancer (BC) remains …
of various human malignant tumors; however, its exact role in bladder cancer (BC) remains …
[HTML][HTML] Expression and role of methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) in bladder cancer
Cancer cells utilize vitamin folate to fulfill their excessive demand for nucleotides and amino
acids. Dihydrofolate reductase (DHFR), an enzyme involved in folate metabolism converts …
acids. Dihydrofolate reductase (DHFR), an enzyme involved in folate metabolism converts …
MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
L Li, Y Zhang, W Hu, F Zou, J Ning… - Journal of Cellular …, 2023 - Wiley Online Library
Although combination chemotherapy is widely used for bladder cancer (BC) treatment, the
recurrence and progression rates remain high. Therefore, novel therapeutic targets are …
recurrence and progression rates remain high. Therefore, novel therapeutic targets are …
Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human …
N Sial, JU Rehman, S Saeed, M Ahmad… - Bioscience …, 2022 - portlandpress.com
Background: Defects in methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L)
expression have earlier been examined in only a few human cancers. Objectives: Multi …
expression have earlier been examined in only a few human cancers. Objectives: Multi …
[HTML][HTML] MTHFD2 overexpression predicts poor prognosis in renal cell carcinoma and is associated with cell proliferation and vimentin-modulated migration and …
H Lin, B Huang, H Wang, X Liu, Y Hong, S Qiu… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: To investigate the role of methylenetetrahydrofolate dehydrogenase 2
(MTHFD2) in the clinical prognosis and cell biology of renal cell carcinoma (RCC). Methods …
(MTHFD2) in the clinical prognosis and cell biology of renal cell carcinoma (RCC). Methods …
Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma
J Chen, J Yang, Q Xu, Z Wang, J Wu, L Pan… - Bioscience …, 2021 - portlandpress.com
Liver hepatocellular carcinoma (LIHC) is one of the most frequently occurring primary
malignant liver tumors and seriously harms people's health in the world …
malignant liver tumors and seriously harms people's health in the world …
[HTML][HTML] NAD-dependent methylenetetrahydrofolate dehydrogenase inhibits oral squamous cell carcinoma cell proliferation and promotes apoptosis
L Zhao, Z Cheng, Z Lu, J Jin - Translational Cancer Research, 2021 - ncbi.nlm.nih.gov
Background NAD-dependent methylenetetrahydrofolate dehydrogenase catalyzes the
conversion of 10-formyltetrahydrofolate to formate in embryonic and adult mammalian …
conversion of 10-formyltetrahydrofolate to formate in embryonic and adult mammalian …
The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines
Purpose Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a tetramethylfolate
dehydrogenase enzyme involved in folate metabolism. The aim of this study is to determine …
dehydrogenase enzyme involved in folate metabolism. The aim of this study is to determine …
Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma
X Liu, Y Huang, C Jiang, H Ou, B Guo, H Liao… - Digestive and Liver …, 2016 - Elsevier
Abstract Background Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is the key
enzyme in the transformation of folic acid metabolites. MTHFD2 overexpression plays a key …
enzyme in the transformation of folic acid metabolites. MTHFD2 overexpression plays a key …
相关搜索
- urothelial carcinomas high level
- urothelial carcinomas poor prognosis
- high level poor prognosis
- urothelial carcinomas immune infiltrates
- high level immune infiltrates
- immune infiltrates poor prognosis
- methylenetetrahydrofolate dehydrogenase poor prognosis
- tumor aggressiveness poor prognosis
- cell proliferation poor prognosis
- immune infiltrates bioinformatics analysis
- migration and invasion poor prognosis
- cell carcinoma poor prognosis
- hepatocellular carcinoma poor prognosis
- hepatocellular carcinoma immune infiltrates